271 related articles for article (PubMed ID: 24157983)
21. Blueprint for the control of radiation-induced nausea and vomiting. Discussion.
Horiot JC
Acta Oncol; 2004 Sep; 43 Suppl 15():23-4. PubMed ID: 15370627
[No Abstract] [Full Text] [Related]
22. Latest advances in the management of radiation-induced pain flare, nausea and vomiting.
Chiu N; Chiu L; Popovic M; DeAngelis C; Pasetka M; Lutz S; Zhang N; Marta GN; Mendez LC; Lechner B; Pulenzas N; Milakovic M; Chow R; Chow E
Ann Palliat Med; 2016 Jan; 5(1):50-7. PubMed ID: 26841815
[TBL] [Abstract][Full Text] [Related]
23. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
Jeremić B
Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
[TBL] [Abstract][Full Text] [Related]
24. Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey.
Vidall C; Fernández-Ortega P; Cortinovis D; Jahn P; Amlani B; Scotté F
Support Care Cancer; 2015 Nov; 23(11):3297-305. PubMed ID: 25953380
[TBL] [Abstract][Full Text] [Related]
25. Evidence-based recommendations for the use of antiemetics in radiotherapy.
Maranzano E; Feyer PCh; Molassiotis A; Rossi R; Clark-Snow RA; Olver I; Warr D; Schiavone C; Roila F;
Radiother Oncol; 2005 Sep; 76(3):227-33. PubMed ID: 16150504
[TBL] [Abstract][Full Text] [Related]
26. [Postoperative nausea and vomiting].
Raeder JC
Tidsskr Nor Laegeforen; 1994 May; 114(13):1526-30. PubMed ID: 8079248
[TBL] [Abstract][Full Text] [Related]
27. Clinical roundtable monograph. Treatment of chemotherapy-induced nausea and vomiting: a post-MASCC 2010 discussion.
Kris MG; Urba SG; Schwartzberg LS
Clin Adv Hematol Oncol; 2011 Jan; 9(1):suppl 1-15. PubMed ID: 21370520
[TBL] [Abstract][Full Text] [Related]
28. Prophylaxis of radiation-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials.
Li WS; van der Velden JM; Ganesh V; Vuong S; Raman S; Popovic M; Lam H; Wong KH; Ngan RK; Burbach JPM; DeAngelis C; Xxxx RM; Chow E
Ann Palliat Med; 2017 Apr; 6(2):104-117. PubMed ID: 28249542
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of prophylactic antiemetic treatment in cancer patients receiving radiotherapy.
Mystakidou K; Kouloulias V; Nikolaou V; Tsilika E; Lymperopoulou G; Balafouta M; Kouvaris I; Kelekis A; Gouliamos A
J BUON; 2010; 15(1):29-35. PubMed ID: 20414924
[TBL] [Abstract][Full Text] [Related]
30. 5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents?
Aapro M; Blower P
Cancer; 2005 Jul; 104(1):1-18. PubMed ID: 15929119
[TBL] [Abstract][Full Text] [Related]
31. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
[TBL] [Abstract][Full Text] [Related]
32. Radiation-induced nausea and vomiting: Is ABO blood group as important as radiation and patient-related factors? An observational study.
Habibi M; Namimoghadam A; Korouni R; Fashiri P; Borzoueisileh S; Elahimanesh F; Amiri F; Moradi G
Medicine (Baltimore); 2016 Aug; 95(31):e4334. PubMed ID: 27495037
[TBL] [Abstract][Full Text] [Related]
33. Granisetron: an update on its clinical use in the management of nausea and vomiting.
Aapro M
Oncologist; 2004; 9(6):673-86. PubMed ID: 15561811
[TBL] [Abstract][Full Text] [Related]
34. 2023 Updated MASCC/ESMO Consensus Recommendations: prevention of radiotherapy- and chemoradiotherapy-induced nausea and vomiting.
Ruhlmann CH; Jordan K; Jahn F; Maranzano E; Molassiotis A; Dennis K
Support Care Cancer; 2023 Dec; 32(1):26. PubMed ID: 38097904
[TBL] [Abstract][Full Text] [Related]
35. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
Herrstedt J
Nat Clin Pract Oncol; 2008 Jan; 5(1):32-43. PubMed ID: 18097455
[TBL] [Abstract][Full Text] [Related]
36. Controlling the toxicity of palliative radiotherapy: the role of 5-HT3 antagonists.
Priestman TJ
Can J Oncol; 1996 Feb; 6 Suppl 1():17-22. PubMed ID: 8853534
[TBL] [Abstract][Full Text] [Related]
37. A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches.
Bossi P; Airoldi M; Aloe Spiriti MA; Antonuzzo A; Bonciarelli G; Campagna A; Cassano A; Murialdo R; Musio D; Silvano G
Expert Opin Drug Saf; 2020 Feb; 19(2):187-204. PubMed ID: 32005072
[No Abstract] [Full Text] [Related]
38. Radiation-induced nausea and vomiting.
Urba S
J Natl Compr Canc Netw; 2007 Jan; 5(1):60-5. PubMed ID: 17239327
[TBL] [Abstract][Full Text] [Related]
39. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
; Wong RK; Paul N; Ding K; Whitehead M; Brundage M; Fyles A; Wilke D; Nabid A; Fortin A; Wilson D; McKenzie M; Ackerman I; Souhami L; Chabot P; Pater J
J Clin Oncol; 2006 Jul; 24(21):3458-64. PubMed ID: 16849762
[TBL] [Abstract][Full Text] [Related]
40. [Chemotherapy-induced nausea and vomiting : Current recommendations for prophylaxis].
Storz E; Gschwend JE; Retz M
Urologe A; 2018 May; 57(5):532-542. PubMed ID: 29589051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
